Serum Institute of India
-

Covishield to be sold for Rs 300 to states, Adar Poonawalla calls it ‘philanthropic gesture’
Scroll Staff
-

Serum Institute chief Adar Poonawalla to get Y category security cover
Scroll Staff
-

Whose intellectual property is Bharat Biotech’s publicly funded Covaxin? India deserves an answer
R Ramakumar
-

Five suggestions for flattening India’s Covid-19 second wave by a Mumbai doctor
Akshay Baheti
-

Covid-19: Serum Institute defends vaccine pricing, says initial rates were based on advance funding
Scroll Staff
-

India’s decision to liberalise vaccine sales likely to push up prices – and block access to millions
R Ramakumar
-

Covid-19: Serum Institute chief urges US to lift export ban to boost vaccine production
Scroll Staff
-

Covid-19: Vaccine production and distribution has exposed – and intensified – global inequality
Jayati Ghosh
-

Top 10 coronavirus updates: Maharashtra reports nearly 60,000 cases in biggest single-day jump
Scroll Staff
-

India temporarily halts export of Covid vaccines to meet local demand as infections surge: Reports
Scroll Staff
-

Increase gap between two doses of Covishield vaccine to 4-8 weeks, Centre tells states
Scroll Staff
-

Coronavirus: Adar Poonawalla warns of raw material shortage for vaccine production due to US law
Scroll Staff
-

Madras HC issues notice to Centre, Serum Institute as volunteer alleges serious trial side effects
Scroll Staff
-

Coronavirus: Hope to launch Covovax vaccine by June, says Serum Institute CEO Adar Poonawalla
Scroll Staff
-

Pune Police, three Maharashtra government agencies start inquiry into Serum Institute fire
Scroll Staff
-

Serum Institute fire: Over Rs 1,000-crore worth damages incurred, says CEO Adar Poonawalla
Scroll Staff
-

Five dead after massive fire at Pune’s Serum Institute plant, Adar Poonawalla says ‘deeply saddened’
Scroll Staff
-

Coronavirus: Serum, Bharat Biotech pledge smooth rollout of vaccine a day after public spat
Scroll Staff
-

Coronavirus: Export of Covishield allowed to all countries, says Serum CEO Adar Poonawalla
Scroll Staff
-

The big news: Two coronavirus vaccines cleared for emergency use in India, and 9 other top stories
Scroll Staff